Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea

Combination therapy with interferon alpha (IFN-α) and ribavirin for 24 or 48 weeks according to HCV genotype has improved the overall sustained virological response (SVR) rates to approximately 40%. The aim of this study was to investigate the long-term efficacy of combination therapy with IFN-α and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jie-Hyun, Han, Kwang-Hyub, Lee, Kwan Sik, Park, Young Nyun, Ahn, Sang Hoon, Chon, Chae Yoon, Moon, Young Myoung
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687818/
https://www.ncbi.nlm.nih.gov/pubmed/17191307
http://dx.doi.org/10.3349/ymj.2006.47.6.793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687818/
https://www.ncbi.nlm.nih.gov/pubmed/17191307
http://dx.doi.org/10.3349/ymj.2006.47.6.793

Ejemplares similares